Back
State Street SPDR S&P Kensho New Econ Comp ETF Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Sell
50
KOMP
State Street SPDR S&P Kensho New Econ Comp ETF
Last Price:
$60.36
Seasonality Move:
-1.16%
Sell
45
ZBIO
Zenas BioPharma, Inc.
Last Price:
$36.38
Seasonality Move:
-8.13%
Sell
50
State Street SPDR S&P Kensho New Econ Comp ETF (KOMP)
is a Sell
Is State Street SPDR S&P Kensho New Econ Comp ETF a Buy, Sell or Hold?
-
The current State Street SPDR S&P Kensho New Econ Comp ETF [KOMP] share price is $60.47. The Score for KOMP is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
KOMP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $36.89. The Score for ZBIO is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
ZBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KOMP Stock Price Chart
What is State Street SPDR S&P Kensho New Econ Comp ETF's stock price today?
-
The State Street SPDR S&P Kensho New Econ Comp ETF share price today is $60.47The current trend is moderately bearish and KOMP is experiencing slight buying pressure.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $36.89The current trend is moderately bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
KOMP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 44.76 | Sell |
| Chaikin Money Flow: | 13306 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.97 | Buy |
| Relative Strength Index (14 RSI): | 51.69 | Buy |
| Chaikin Money Flow: | 321584 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
KOMP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.85 | Sell |
| 20-day SMA: | 60.68 | Sell |
| 50-day SMA: | 62.34 | Sell |
| 200-day SMA: | 55.27 | Buy |
| 8-day EMA: | 61.44 | Sell |
| 20-day EMA: | 61.39 | Sell |
| 50-day EMA: | 60.33 | Buy |
| 200-day EMA: | 38.15 | Buy |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.29 | Sell |
| 20-day SMA: | 37.71 | Sell |
| 50-day SMA: | 32.54 | Buy |
| 200-day SMA: | 17.6 | Buy |
| 8-day EMA: | 37.45 | Sell |
| 20-day EMA: | 34.56 | Buy |
| 50-day EMA: | 23.69 | Buy |
| 200-day EMA: | 8.26 | Buy |
State Street SPDR S&P Kensho New Econ Comp ETF Earnings Growth & KOMP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.
State Street SPDR S&P Kensho New Econ Comp ETF Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||